News News Beike Finance News on July 25, the Hengrui Medicine announced that the company plans to get 1.4587% of the equity of Chengdu Shengdi Pharmaceutical Co., Ltd. Holding Liu Jiang, Zhou Yunshu, Jiang Sumumei, Sun Xugen, Lu Zhengqing, Jiang Xinhua, Yuan Yongjiang and Wu Yuxia for a cash of 401.44亿元人民币和其他股东已将其首次拒绝的权利投降。完成这项交易后，公司将持有成都尚迪的股权的97.3866％，并且合并财务报表的范围不会因获得此权益而不会改变。